Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001626199-21-000127
Filing Date
2021-09-24
Accepted
2021-09-24 18:39:05
Documents
1
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163252313299208.html 4  
1 FORM 4 wf-form4_163252313299208.xml 4 3718
  Complete submission text file 0001626199-21-000127.txt   5391
Mailing Address C/O ARCA BIOPHARMA, INC 8001 ARISTA PLACE, STE 430 BROOMFIELD CO 80021
Business Address
CONWAY ROBERT E (Reporting) CIK: 0001184334 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 211278537

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations